Artificial Intelligence in Medication Research and Development: The Pharmaceutical Industry's Future

Area of Science:

• Pharmaceutical Sciences
• Computer Science
• Biotechnology

Background:

• Artificial intelligence (AI) is increasingly adopted in the pharmaceutical industry.
• AI offers significant potential to improve drug discovery and development processes.
• Machine learning and deep learning are key AI technologies driving innovation.

Purpose of the Study:

• To highlight the impact and benefits of AI in drug development.
• To explore the applications of AI in various stages of the pharmaceutical pipeline.
• To identify challenges and future directions for AI in drug discovery.

Main Methods:

• Review of current AI applications in drug development.
• Analysis of AI's role in predicting drug properties and identifying targets.
• Examination of AI's contribution to small molecule drug development and clinical trial acceleration.

Main Results:

• AI significantly enhances speed, accuracy, and cost-effectiveness in drug development.
• Proven applications include property prediction, target validation, and small molecule development.
• AI aids in accelerating clinical trials through drug repurposing and outcome predictions.

Conclusions:

• AI presents transformative potential for the pharmaceutical industry.
• Addressing challenges in data sharing and algorithm standardization is crucial for further progress.
• Integrating biology and computer science will optimize AI's impact on drug development.